Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ALK1 inhibitors(Activin receptor-like kinase 1 inhibitors), ALK2 inhibitors(Activin receptor type-1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H31FN4O2 |
InChIKeyRIWTUJFFSTVYPW-UHFFFAOYSA-N |
CAS Registry2421141-51-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Preclinical | DE | 18 Jul 2024 |